ScreenerHero
TMOThermo Fisher Scientific Inc.
NYSE · US · Healthcare · Diagnostics & Research · thermofisher.com
625.57USD+1.96%Mkt Cap: 226.85B $P/E: 33.07

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Scien…

Industry Peers

Diagnostics & Research
Screen all
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD
RDNT
RadNet, Inc.
$5.94BUSD

Key Statistics

Company
Market Cap226.85B $
Enterprise Value270.65B $
Revenue (TTM)46.34B $
Gross Profit18.24B $
Net Income (TTM)6.70B $
Revenue/Share123.89 USD
Last Price625.57 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees125.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS8835561023
Valuation
P/E (Trailing)33.07
P/E (Forward)22.81
PEG2.00
EV/EBITDA23.05
EV/Revenue5.84
P/S5.01
P/B4.40
EPS (TTM)19.01
EPS (Forward)27.51
52W Range
435.2791% of range643.99
52W High643.99 USD
52W Low435.27 USD
Profitability
Gross Margin40.93%
Oper. Margin18.75%
EBITDA Margin25.34%
Profit Margin15.05%
ROE12.55%
ROA6.08%
Growth
Revenue Growth10.50%
Earnings Growth9.40%
Cash Flow & Leverage
Operating CF7.82B $
CapEx (TTM)1.52B $
FCF Margin13.46%
FCF Yield2.75%
Net Debt38.48B $
Net Debt/EBITDA3.28
Balance Sheet
Debt/Equity0.74
Current Ratio1.55
Quick Ratio1.01
Book Value/Sh142.47 USD
Cash/Share10.99 USD
Dividends
Fwd Div Rate1.880 USD
Trail. Div Rate1.800 USD
Div. Yield0.31%
5Y Avg Yield0.26%
Payout Ratio9.69%
Ex-Div DateSep 15, 2026
Pay DateOct 15, 2026
Splits
Last Split3:2
Split DateJun 6, 1996
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)631.42 USD
Upside (mean)+0.9%
Target Range520.00 USD – 750.00 USD
$520.00+0.9% to mean$750.00
# Analysts26
Ownership
Shares Out.369.75M
Float368.82M
Insiders0.13%
Institutions94.42%
Short Interest
Short Ratio2.2d
Short % Float1.35%
Short % Out.1.35%
Shares Short4.99M
Short (prev mo.)5.35M
Technical
SMA 50538.73 (+16.1%)
SMA 200533.48 (+17.3%)
Beta0.85
S&P 52W Chg18.16%
Avg Vol (30d)1.57M
Avg Vol (10d)1.76M
Technical Indicators
RSI (14)70.2
MACD19.1949
MACD Signal19.6835
MACD Hist.-0.4886
BB Upper619.08 USD
BB Middle580.60 USD
BB Lower542.13 USD
BB Width13.25%
ATR (14)16.02 USD
Vol Ratio (20d)0.98x